Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
A New Rabies Vaccine Based on a Recombinant Orf Virus (Parapoxvirus) Expressing the Rabies Virus Glycoprotein
- R. Amann, Jörg Rohde, +4 authors H. Rziha
- Biology, Medicine
- Journal of Virology
- 21 November 2012
ABSTRACT The present study describes the generation of a new Orf virus (ORFV) recombinant, D1701-V-RabG, expressing the rabies virus (RABV) glycoprotein that is correctly presented on the surface of… Expand
Efficacy and safety of a feline immunodeficiency virus vaccine.
- C. Huang, Douglas Conlee, Jennifer Loop, D. Champ, M. Gill, Hsien-Jue Steve Chu
- Biology, Medicine
- Animal health research reviews
- 1 December 2004
Fel-O-Vax FIV is an inactivated virus vaccine designed as an aid in the prevention of infection of cats, 8 weeks or older, by feline immunodeficiency virus (FIV). It contains two genetically distinct… Expand
Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge
- C. Huang, Douglas Conlee, M. Gill, Hsien-Jue Steve Chu
- Medicine
- Journal of feline medicine and surgery
- 1 June 2010
The duration of immunity of the dual-subtype feline immunodeficiency virus (FIV) vaccine, Fel-O-Vax FIV, for protection against subtype-B FIV was assessed in this study. Vaccinated cats along with… Expand
Vaccination with an inactivated canine influenza H3N2 virus vaccine is safe and elicits an immune response in cats
- Sridhar Velineni, Nicole Hainer, Douglas Conlee, Kendra Hutchinson
- Medicine
- Journal of feline medicine and surgery
- 14 March 2019
Objectives The aim of this study was to evaluate safety and seroconversion when an inactivated H3N2 canine influenza virus (CIV) vaccine was administered to cats. Methods Twenty 7–8-week-old… Expand